Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
about
Simulation predicts IGFBP2-HIF1α interaction drives glioblastoma growthRedundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation.Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLCγ1M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Modelling the molecular mechanisms of aging.VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways.
P2860
Q28546518-C73C3F72-2E14-45A5-83C8-A96FC31FD352Q34704781-09E7F3DC-006C-42B6-8D4A-8DE608339528Q35918864-92C95F12-4587-42EB-9D45-FE1042ECA345Q36354166-312C0068-05E0-4921-80E7-C3D5744DD22BQ36996343-B41A84F2-7D7F-4D51-BCE1-D4DCE33BB195Q37699298-AD24BEFC-1615-4E21-B4C8-B34838D4E6FAQ38454084-51B283E3-3D9A-4187-8A69-3608391C4B35Q38769316-B9F6A548-EE14-40D7-BA85-B0EFC2093195Q47100851-6C39299D-BD73-4D7B-99BE-E3C0DA26035A
P2860
Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@ast
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@en
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@nl
type
label
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@ast
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@en
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@nl
prefLabel
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@ast
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@en
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@nl
P2860
P1433
P1476
Analysis of the quantitative b ...... vity and therapeutic efficacy.
@en
P2093
P2860
P2888
P356
10.1186/S12918-014-0098-Y
P577
2014-08-13T00:00:00Z